168 related articles for article (PubMed ID: 18245010)
1. Application of PET/CT in the development of novel anticancer drugs.
Boss DS; Olmos RV; Sinaasappel M; Beijnen JH; Schellens JH
Oncologist; 2008 Jan; 13(1):25-38. PubMed ID: 18245010
[TBL] [Abstract][Full Text] [Related]
2. PET/CT for the staging and follow-up of patients with malignancies.
Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
[TBL] [Abstract][Full Text] [Related]
3. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925
[TBL] [Abstract][Full Text] [Related]
4. Integrated PET/CT and cancer imaging.
De Wever W; Coolen J; Verschakelen JA
JBR-BTR; 2009; 92(1):13-9. PubMed ID: 19358480
[TBL] [Abstract][Full Text] [Related]
5. [(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer.
Tuncel M; Souvatzoglou M; Herrmann K; Stollfuss J; Schuster T; Weirich G; Wester HJ; Schwaiger M; Krause BJ
Nucl Med Biol; 2008 Aug; 35(6):689-95. PubMed ID: 18678354
[TBL] [Abstract][Full Text] [Related]
6. Computed tomography, positron emission tomography, positron emission tomography/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results.
Plathow C; Staab A; Schmaehl A; Aschoff P; Zuna I; Pfannenberg C; Peter SH; Eschmann S; Klopp M
Invest Radiol; 2008 Oct; 43(10):737-44. PubMed ID: 18791416
[TBL] [Abstract][Full Text] [Related]
7. The clinician's expectations from the use of positron emission tomography/computed tomography scanning in untreated and treated head and neck cancer patients.
Fleming AJ; Johansen ME
Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):127-34. PubMed ID: 18327031
[TBL] [Abstract][Full Text] [Related]
8. PET and PET/CT studies of tumor tissue oxygenation.
Krause BJ; Beck R; Souvatzoglou M; Piert M
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):28-43. PubMed ID: 16557202
[TBL] [Abstract][Full Text] [Related]
9. Tumor biology-guided radiotherapy treatment planning: gross tumor volume versus functional tumor volume.
Guha C; Alfieri A; Blaufox MD; Kalnicki S
Semin Nucl Med; 2008 Mar; 38(2):105-13. PubMed ID: 18243845
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer therapy: the role of PET-CT in decision making.
Pons F; Duch J; Fuster D
Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):210-23. PubMed ID: 19293769
[TBL] [Abstract][Full Text] [Related]
11. The evolving role of PET-CT in the management of esophageal cancer.
Chuang HH; Macapinlac HA
Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):201-9. PubMed ID: 19293768
[TBL] [Abstract][Full Text] [Related]
12. Interpretation of treatment results with biological agents: is there a need for a new methodology?
Begent RH
J BUON; 2007 Sep; 12 Suppl 1():S53-8. PubMed ID: 17935278
[TBL] [Abstract][Full Text] [Related]
13. Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer.
Gourin CG; Boyce BJ; Williams HT; Herdman AV; Bilodeau PA; Coleman TA
Laryngoscope; 2009 Nov; 119(11):2150-5. PubMed ID: 19544378
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma.
Tateishi U; Hosono A; Makimoto A; Nakamoto Y; Kaneta T; Fukuda H; Murakami K; Terauchi T; Suga T; Inoue T; Kim EE
Ann Nucl Med; 2009 Feb; 23(2):155-61. PubMed ID: 19225939
[TBL] [Abstract][Full Text] [Related]
15. Molecular PET/CT imaging-guided radiation therapy treatment planning.
Zaidi H; Vees H; Wissmeyer M
Acad Radiol; 2009 Sep; 16(9):1108-33. PubMed ID: 19427800
[TBL] [Abstract][Full Text] [Related]
16. [Application of molecular imaging to chemotherapy].
Fan W; Zhi SF; Liu JL
Ai Zheng; 2006 Jan; 25(1):122-5. PubMed ID: 16405766
[TBL] [Abstract][Full Text] [Related]
17. Added value of PET and PET-CT in oesophageal cancer: a review of current practice.
Vinjamuri S; Ray S
Nucl Med Commun; 2008 Jan; 29(1):4-10. PubMed ID: 18049091
[TBL] [Abstract][Full Text] [Related]
18. Selecting a new PET/CT system.
Madsen MT
J Am Coll Radiol; 2004 May; 1(5):356-8. PubMed ID: 17411602
[No Abstract] [Full Text] [Related]
19. Advanced imaging for veterinary cancer patients.
LeBlanc AK; Daniel GB
Vet Clin North Am Small Anim Pract; 2007 Nov; 37(6):1059-77; v-i. PubMed ID: 17950882
[TBL] [Abstract][Full Text] [Related]
20. Imaging vascular physiology to monitor cancer treatment.
Laking GR; West C; Buckley DL; Matthews J; Price PM
Crit Rev Oncol Hematol; 2006 May; 58(2):95-113. PubMed ID: 16387510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]